...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy

"AOC 1020" Now on FDA’s Fast Track as FSHD Treatment

 
I believe the Muscular Dystrophy Association considered using "apabetalone" in the study a few years back. 
 
 
Koo

 

Share
New Message
Please login to post a reply